PHASE II TRIAL OF HIGH-DOSE GEMCITABINE/BUSULFAN/MELPHALAN WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR PRIMARY REFRACTORY OR POOR-RISK RELAPSED HODGKIN’S LYMPHOMA

We conducted a prospective phase 2 trial of gemcitabine, busulfan and melphalan (Gem/Bu/Mel) with autologous stem-cell transplantation (ASCT) in Hodgkin’s lymphoma (HL) patients with primary refractory or poor-risk relapsed disease (extranodal relapse or within 1 year of frontline therapy). The tria...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Biol Blood Marrow Transplant
Main Authors: Nieto, Yago, Thall, Peter F, Ma, Junsheng, Valdez, Benigno C, Ahmed, Sairah, Anderlini, Paolo, Popat, Uday, Jones, Roy B, Shpall, Elizabeth J, Hosing, Chitra, Qazilbash, Muzaffar, Kebriaei, Partow, Alousi, Amin, Timmons, Melissa, Gulbis, Alison, Myers, Alan, Oki, Yasuhiro, Fanale, Michelle, Dabaja, Bouthaina, Pinnix, Chelsea, Milgrom, Sarah, Champlin, Richard, Andersson, Borje S
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2018
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8212703/
https://ncbi.nlm.nih.gov/pubmed/29501779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.02.020
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla